isoflurophate has been researched along with Cell Transformation, Neoplastic in 18 studies
Isoflurophate: A di-isopropyl-fluorophosphate which is an irreversible cholinesterase inhibitor used to investigate the NERVOUS SYSTEM.
Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (94.44) | 18.7374 |
| 1990's | 1 (5.56) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, HY | 1 |
| Peltz, SW | 1 |
| Mangel, WF | 1 |
| Karpatkin, S | 1 |
| Pearlstein, E | 1 |
| Salk, PL | 1 |
| Yogeeswaran, G | 1 |
| Singer, KH | 1 |
| Hashimoto, K | 1 |
| Stuhlmiller, GM | 1 |
| Lazarus, GS | 1 |
| Mak, TW | 1 |
| Rutledge, G | 1 |
| Sutherland, DJ | 1 |
| Poste, G | 1 |
| Roblin, RO | 1 |
| Hammond, ME | 1 |
| Bensky, ND | 1 |
| Dvorak, AM | 1 |
| Dvorak, HF | 1 |
| Black, PH | 1 |
| Gordon, SG | 1 |
| Lewis, BJ | 1 |
| Mahdavi, V | 1 |
| Hynes, RO | 1 |
| Danø, K | 1 |
| Reich, E | 3 |
| Berkenpas, MB | 1 |
| Quigley, JP | 1 |
| de Kok, AJ | 1 |
| Sips, H | 1 |
| Chang, GT | 1 |
| Verheijen, JH | 1 |
| Messadi, DV | 1 |
| Billings, P | 1 |
| Shklar, G | 1 |
| Kennedy, AR | 2 |
| Sim, PS | 1 |
| Stephens, RW | 1 |
| Fayle, DR | 1 |
| Doe, WF | 1 |
| Billings, PC | 1 |
| Carew, JA | 1 |
| Keller-McGandy, CE | 1 |
| Goldberg, AL | 1 |
| Christman, JK | 1 |
| Acs, G | 1 |
| Unkeless, J | 1 |
| Dano, K | 1 |
| Kellerman, GM | 1 |
| Unkeless, JC | 1 |
| Gordon, S | 1 |
| Glow, PH | 1 |
18 other studies available for isoflurophate and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Modulation of the plasminogen activator activity of a transformed cell line by cell density.
Topics: Animals; Cell Count; Cell Line; Cell Transformation, Neoplastic; Isoflurophate; Kinetics; Plasminoge | 1982 |
Role of platelets in tumor cell metastases.
Topics: Animals; Blood Coagulation Factors; Blood Platelets; Cell Line; Cell Transformation, Neoplastic; Cen | 1981 |
Antibody-induced release of cellular proteinases: loss of adhesion of human melanoma cells after binding of anti-melanoma antibody.
Topics: Animals; Cell Adhesion; Cell Line; Cell Transformation, Neoplastic; Endopeptidases; Female; Humans; | 1982 |
Androgen-dependent fibrinolytic activity in a murine mammary carcinoma (Shionogi SC-115 cells) in vitro.
Topics: Aminocaproates; Animals; Benzoates; Cell Division; Cell Transformation, Neoplastic; Cells, Cultured; | 1976 |
Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
Topics: Animals; Avian Sarcoma Viruses; Cell Line; Cell Migration Inhibition; Cell Transformation, Neoplasti | 1975 |
Generation of macrophage migration inhibitory activity by plasminogen activators.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Guinea Pigs; Isoflurophate; Macrophage Migratio | 1977 |
Comparison of procoagulant activity in tissue culture medium from normal and transformed fibroblasts.
Topics: Blood Coagulation; Cell Transformation, Neoplastic; Coagulants; Culture Techniques; Isoflurophate; N | 1978 |
Proteolytic enzymes in normal and transformed cells.
Topics: Animals; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; Fibroblasts; Isoflurophate; M | 1979 |
Serine enzymes released by cultured neoplastic cells.
Topics: Binding Sites; Cell Transformation, Neoplastic; Cells, Cultured; Enzyme Inhibitors; Esterases; Human | 1978 |
Transformation-dependent activation of urokinase-type plasminogen activator by a plasmin-independent mechanism: involvement of cell surface membranes.
Topics: Amino Acid Sequence; Animals; Avian Sarcoma Viruses; Cell Membrane; Cell Transformation, Neoplastic; | 1991 |
Enhanced plasminogen activator production of Syrian hamster embryo cells transformed by chemicals or the c-Ha-ras oncogene: type of plasminogen activators involved and their contribution to the transformed phenotype.
Topics: Animals; Antibodies; Benzo(a)pyrene; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cricet | 1989 |
Inhibition of oral carcinogenesis by a protease inhibitor.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Cell Transformation, Neoplastic; Cricetinae; Diethyl Pyro | 1986 |
Urokinase-type plasminogen activator in colorectal carcinomas and adenomatous polyps: quantitative expression of active and proenzyme.
Topics: Adenoma; Antibodies, Monoclonal; Cell Transformation, Neoplastic; Colonic Polyps; Colorectal Neoplas | 1988 |
A serine protease activity in C3H/10T1/2 cells that is inhibited by anticarcinogenic protease inhibitors.
Topics: Animals; Cell Line; Cell Transformation, Neoplastic; Coumarins; Endopeptidases; Fibroblasts; Isoflur | 1987 |
Purification and characterization of a cellular fibrinolytic factor associated with oncogenic transformation: the plasminogen activator from SV-40-transformed hamster cells.
Topics: Animals; Binding Sites; Cell Transformation, Neoplastic; Chromatography, Ion Exchange; Clone Cells; | 1974 |
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.
Topics: Animals; Avian Sarcoma Viruses; Cell Fractionation; Cell Transformation, Neoplastic; Chick Embryo; C | 1974 |
Secretion of plasminogen activator by stimulated macrophages.
Topics: Amino Acids; Animals; Carbon Radioisotopes; Cell Transformation, Neoplastic; Cells, Cultured; Electr | 1974 |
Incidence of chromophobe adenoma after chronic diisopropylfluorophosphate poisoning.
Topics: Adenoma, Chromophobe; Animals; Cell Transformation, Neoplastic; Female; Isoflurophate; Neoplasms, Ex | 1969 |